Global Prostaglandin Market Valued at around USD 400 Million
in 2018 and Expected to Surpass more than USD 600 Million by
2027
The report titled “Prostaglandin Market: Global Demand Analysis &
Opportunity Outlook 2027” delivers detailed overview of the
Prostaglandin Market in terms of market segmentation by product type, by
application and by region.
The global prostaglandin market was valued at around USD 400 Million in
2018 and is expected to surpass more than USD 600 Million by 2027. The
market is anticipated to record a CAGR of 4% during the forecast period i.e.
2019-2027. The market is segmented by product type into human and
veterinary prostaglandin out of which, the proportion of human
prostaglandin was about 84% in 2018 owing to the more generation of
prostaglandin in humans. The market is further segmented by application
into digestive, cardiovascular, gynecological, and ophthalmologic and others
out of which, the proportion of cardiovascular application.
North America region is anticipated to have largest share in the market
owing to increasing geriatric population, growing incidences of glaucoma
and increasing investments in the pharmaceutical industry. Europe and Asia
Pacific region are expected to witness significant growth and contribute to
the revenue in the market during the forecast period.
Prostaglandin are hormones present in the body that control various
processes in the body especially related to healing process. When the tissue
is damaged or infected, these hormones create reactions that cause pain,
inflammation and fever which stimulates the healing process, the formation
of blood clot and contraction of the blood vessel when the body is bleeding.